Arch Therapeutics Inc (ARTH)

[divea]

LaddyMan,
Thank you for doing your own reasearch. I did not intend to be disingenuous in any way. I said VetiGel is approved and in use. I don't think investors care if the product is being used on animals or humans, the point is there are SALES of the product, but you are right the TraumaGel is to be FDA approved this fiscal quarter. ALSO, the makers of VetiGel (Suneris) are partnered with Vet Plus and have resources for manufacturing and marketing and SELLING their product unlike ARTH that has not even a plan for manufacturing, marketing or selling their product. TRAUMAGEL is partnered with Cresilon for manufacturing, marketing and SELLING of a product even before FDA approval.
ALSO, Look up VitaGEL which IS a surgical hemostat with FDA approved class III medical device. www.orthovita.com. My point was that there are other products out there that will or have approval and ARTH is not the leader in this technology.
Also, Traumagel Is already being used in combat situations and what better customer to have than the Federal government with deep pockets.
I apologize if anyone thought I was being disingenuous. I have no agenda on this board except to give information as I know it and let the investors make their own decisions.
Full disclosure, I was "spurned" by Avtar Dhillon once with another stock before I did my research and I am only letting others know so the can do their own DD.